Sort
64,565 grants matching “drug discovery”
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$1,500,000Bernard Mark Evers · University Of Kentucky · P30 · FY2014 · CA
Collaborative Research: Frameworks: Interoperable High-Performance Classical, Machine Learning and Quantum Free Energy Methods in AMBER
$1,500,000Darrin M York · Rutgers University New Brunswick · · FY2022 · CSE
The CFDE Workbench
$1,500,000Avi Ma'ayan · Icahn School Of Medicine At Mount Sinai · OT2 · FY2023 · OD
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2010 · DK
Development and Commercialization of the Microphysiological Systems Database as a Sustainable Resource
$1,499,999Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U24 · FY2021 · TR
Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (Doula)
$1,499,999Lisa A Marsch · Dartmouth College · UG1 · FY2025 · DA
Utah Trial Innovation Center
$1,499,994Jonathan Michael Dean · University Of Utah · U24 · FY2016 · TR
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN)
$1,499,981Norman J Haughey · Johns Hopkins University · P30 · FY2022 · MH
A microfluidic-enabled SmartPlate for precision culture, control and monitoring of living cells. NAICS 5417715 PSC AN12 Contractor DUNS 078744267
$1,499,968Mary Ludlam · Cairn Biosciences, Inc. · N01 · FY2018 · DA
Novel Protease Inhibitors as SARS Therapeutics
$1,499,929Michael E. Johnson · University Of Illinois At Chicago · P01 · FY2006 · AI
Development of a novel, preferring potentiator of GABAA receptor for treatment of epilepsy
$1,499,869Rok Cerne · Respirerx Pharmaceuticals Inc. · R44 · FY2025 · NS
UAB Center for AIDS Research
$1,499,409Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2018 · AI
Emory-GSK-NIMH Collaborative Mood Disorders Initiative
$1,499,366Emory University · U19 · FY2005 · MH
Preclinical development of AST-004 for astrocyte-mediated treatment of TBI.
$1,499,342Theodore E Liston · Astrocyte Pharmaceuticals, Inc. · R44 · FY2019 · NS
Fox COBRE Phase II Admin Core
$1,498,202Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
CHEMICAL GENETIC APPROACHES TO BASIC CELL BIOLOGY
$1,498,111Harvard University (Medical School) · P01 · FY2004 · GM
NICHD: R&D: PRECLINICAL SAFETY AND TOXICOLOGY STUDIES FOR REGULATORY REQUIREMENTS: NON-SEVERABLE
$1,497,846Deborah Bunin · Sri International · N01 · FY2025 · HD
Novel Protease Inhibitors as SARS Therapeutics
$1,497,577Michael E. Johnson · University Of Illinois At Chicago · P01 · FY2007 · AI
Functional Genomics of Bipolar Disorder
$1,497,299Francis J McMahon · National Institute Of Mental Health · ZIA · FY2016 · MH
Phase IIa study of VBP15 for Duchenne muscular dystrophy
$1,496,525Eric P Hoffman · Reveragen Biopharma, Inc. · R44 · FY2017 · NS
Preclinical development of AST-004 for astrocyte-mediated treatment of TBI.
$1,496,476Theodore E Liston · Astrocyte Pharmaceuticals, Inc. · R44 · FY2018 · NS
Phase IIa study of VBP15 for Duchenne muscular dystrophy
$1,495,253Eric P Hoffman · Reveragen Biopharma, Inc. · R44 · FY2016 · NS
Medical University of South Carolina - Cancer Center Support Grant
$1,495,000Anthony J Alberg · Medical University Of South Carolina · P30 · FY2014 · CA
Medical University of South Carolina - Cancer Center Support Grant
$1,495,000Anthony J Alberg · Medical University Of South Carolina · P30 · FY2015 · CA
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
$1,494,740Tor C. Savidge · Baylor College Of Medicine · U01 · FY2017 · AI